IL147747A0 - Enzyme catalyzed anti-infective therapeutic agents - Google Patents
Enzyme catalyzed anti-infective therapeutic agentsInfo
- Publication number
- IL147747A0 IL147747A0 IL14774700A IL14774700A IL147747A0 IL 147747 A0 IL147747 A0 IL 147747A0 IL 14774700 A IL14774700 A IL 14774700A IL 14774700 A IL14774700 A IL 14774700A IL 147747 A0 IL147747 A0 IL 147747A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agents
- enzyme catalyzed
- infective therapeutic
- catalyzed anti
- infective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/556—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells enzyme catalyzed therapeutic agent [ECTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14536499P | 1999-07-22 | 1999-07-22 | |
US15310199P | 1999-09-09 | 1999-09-09 | |
PCT/US2000/019844 WO2001007087A2 (en) | 1999-07-22 | 2000-07-21 | Enzyme catalyzed anti-infective therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IL147747A0 true IL147747A0 (en) | 2002-08-14 |
Family
ID=26842894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14774700A IL147747A0 (en) | 1999-07-22 | 2000-07-21 | Enzyme catalyzed anti-infective therapeutic agents |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1202749A2 (en) |
JP (1) | JP2003527317A (en) |
KR (1) | KR20020059340A (en) |
CN (1) | CN1391487A (en) |
AU (1) | AU6358900A (en) |
CA (1) | CA2379834A1 (en) |
IL (1) | IL147747A0 (en) |
MX (1) | MXPA02000761A (en) |
WO (1) | WO2001007087A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9708611D0 (en) * | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
US6703374B1 (en) | 1997-10-30 | 2004-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleosides for imaging and treatment applications |
MXPA02000762A (en) * | 1999-07-22 | 2002-08-20 | Newbiotics Inc | Methods for treating therapy resistant tumors. |
GB0009486D0 (en) | 2000-04-17 | 2000-06-07 | Univ Cardiff | Chemical compounds |
AU2001277093A1 (en) * | 2000-07-20 | 2002-02-05 | Newbiotics, Inc. | Methods for identifying therapeutic targets |
US6987180B2 (en) | 2002-02-07 | 2006-01-17 | President And Fellows Of Harvard College | Uridine analogs and techniques for making and using |
GB0609178D0 (en) | 2006-05-09 | 2006-06-21 | Univ Cardiff | Novel compounds |
CN104497083B (en) * | 2014-05-12 | 2017-07-07 | 河南师范大学 | Nucleosides phenylpropen ketone hybrid with Antiparasitic Activity and its preparation method and application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9323008D0 (en) * | 1993-11-05 | 1994-01-05 | Connors Thomas | Improvements relating to cancer therapy |
WO1999006072A1 (en) * | 1997-07-30 | 1999-02-11 | Boehringer Mannheim Corporation | Cyclized prodrugs |
DE69900841T2 (en) * | 1998-01-23 | 2002-10-02 | Newbiotics Inc., San Diego | THERAPEUTIC SUBSTANCES OBTAINED BY ENZYM CATALYSIS. |
JP2003518000A (en) * | 1998-12-11 | 2003-06-03 | コールター ファーマシューティカル,インコーポレイティド | Prodrug compound and method for preparing the same |
MXPA02000762A (en) * | 1999-07-22 | 2002-08-20 | Newbiotics Inc | Methods for treating therapy resistant tumors. |
-
2000
- 2000-07-21 IL IL14774700A patent/IL147747A0/en unknown
- 2000-07-21 KR KR1020027000936A patent/KR20020059340A/en not_active Application Discontinuation
- 2000-07-21 CA CA002379834A patent/CA2379834A1/en not_active Abandoned
- 2000-07-21 MX MXPA02000761A patent/MXPA02000761A/en unknown
- 2000-07-21 AU AU63589/00A patent/AU6358900A/en not_active Abandoned
- 2000-07-21 WO PCT/US2000/019844 patent/WO2001007087A2/en not_active Application Discontinuation
- 2000-07-21 CN CN00813015A patent/CN1391487A/en active Pending
- 2000-07-21 JP JP2001511970A patent/JP2003527317A/en not_active Withdrawn
- 2000-07-21 EP EP00950490A patent/EP1202749A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1202749A2 (en) | 2002-05-08 |
JP2003527317A (en) | 2003-09-16 |
KR20020059340A (en) | 2002-07-12 |
CA2379834A1 (en) | 2001-02-01 |
CN1391487A (en) | 2003-01-15 |
AU6358900A (en) | 2001-02-13 |
MXPA02000761A (en) | 2002-08-12 |
WO2001007087A3 (en) | 2002-01-17 |
WO2001007087A8 (en) | 2001-07-12 |
WO2001007087A2 (en) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9911863D0 (en) | Therapeutic agents | |
GB9905010D0 (en) | Therapeutic agents | |
IL150030A0 (en) | Therapeutic agents | |
GB9904786D0 (en) | Therapeutic agents | |
GB9929685D0 (en) | Therapeutic agents | |
GB9929687D0 (en) | Therapeutic agents | |
GB9911881D0 (en) | Therapeutic agents | |
GB9921351D0 (en) | Therapeutic agents | |
GB9903476D0 (en) | Therapeutic agents | |
GB9929569D0 (en) | Therapeutic agents | |
IL147747A0 (en) | Enzyme catalyzed anti-infective therapeutic agents | |
GB9914745D0 (en) | Therapeutic agents | |
GB9914744D0 (en) | Therapeutic agents | |
GB9903119D0 (en) | Therapeutic agents | |
EP1242064A4 (en) | Liver selective therapy | |
IL147078A0 (en) | Therapeutic agents | |
GB9902881D0 (en) | Therapeutic agents | |
GB0025890D0 (en) | Gene therapy | |
GB9900009D0 (en) | Gene therapy | |
GB9914743D0 (en) | Therapeutic agents | |
GB0406539D0 (en) | Gene therapy | |
GB9915616D0 (en) | Therapeutic agents | |
GB9906124D0 (en) | Therapeutic agent | |
GB9918057D0 (en) | Therapeutic agents | |
GB9915617D0 (en) | Therapeutic agents |